208 related articles for article (PubMed ID: 7684861)
21. The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.
Han SH; de Klerk JM; Tan S; van het Schip AD; Derksen BH; van Dijk A; Kruitwagen CL; Blijham GH; van Rijk PP; Zonnenberg BA
J Nucl Med; 2002 Sep; 43(9):1150-6. PubMed ID: 12215552
[TBL] [Abstract][Full Text] [Related]
22. Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer.
Bishayee A; Rao DV; Srivastava SC; Bouchet LG; Bolch WE; Howell RW
J Nucl Med; 2000 Dec; 41(12):2043-50. PubMed ID: 11138691
[TBL] [Abstract][Full Text] [Related]
23. Strontium 89 in the treatment of bony metastases.
Porter AT; Ben-Josef E
Important Adv Oncol; 1995; ():87-94. PubMed ID: 7545646
[No Abstract] [Full Text] [Related]
24. Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153.
Guerra Liberal FDC; Tavares AAS; Tavares JMRS
Appl Radiat Isot; 2016 Apr; 110():87-99. PubMed ID: 26773820
[TBL] [Abstract][Full Text] [Related]
25. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
Klutmann S; Bohuslavizki KH
MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142
[TBL] [Abstract][Full Text] [Related]
26. "Naked" radiopharmaceuticals.
Wallner PE
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S60-1. PubMed ID: 16979442
[TBL] [Abstract][Full Text] [Related]
27. Targeted radionuclide therapy for bone metastases.
Lewington VJ
Eur J Nucl Med; 1993 Jan; 20(1):66-74. PubMed ID: 7678397
[TBL] [Abstract][Full Text] [Related]
28. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
Silberstein EB
Semin Nucl Med; 2005 Apr; 35(2):152-8. PubMed ID: 15765378
[TBL] [Abstract][Full Text] [Related]
29. Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy.
Papatheofanis FJ
J Nucl Med; 1999 Sep; 40(9):1420-3. PubMed ID: 10492359
[TBL] [Abstract][Full Text] [Related]
30. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
Flamm J; Burkert S
Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
[TBL] [Abstract][Full Text] [Related]
31. Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatment.
de Klerk JM; Zonnenberg BA; Krouwer HG; Blijham GH; van Dijk A; van het Schip AD; van Die J; van Rijk PP
J Nucl Med; 1996 Mar; 37(3):465-7. PubMed ID: 8772646
[TBL] [Abstract][Full Text] [Related]
32. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
Kan MK
Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
[TBL] [Abstract][Full Text] [Related]
33. New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
Williams JE
J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327
[No Abstract] [Full Text] [Related]
34. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ
Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235
[TBL] [Abstract][Full Text] [Related]
35. Internally administered isotopes in the treatment of solid malignancy.
Willett CG
J Nucl Med; 1990 May; 31(5):601-2. PubMed ID: 2341895
[No Abstract] [Full Text] [Related]
36. Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.
Srivastava SC; Atkins HL; Krishnamurthy GT; Zanzi I; Silberstein EB; Meinken G; Mausner LF; Swailem F; D'Alessandro T; Cabahug CJ; Lau Y; Park T; Madajewicz S
Clin Cancer Res; 1998 Jan; 4(1):61-8. PubMed ID: 9516953
[TBL] [Abstract][Full Text] [Related]
37. Samarium-153 lexidronam for painful bone metastases.
Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
[No Abstract] [Full Text] [Related]
38. ESR dosimetry of 89Sr and 153Sm in bone.
Kinoshita A; Braga FJ; Graeff CF; Baffa O
Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
[TBL] [Abstract][Full Text] [Related]
39. WITHDRAWN: Radioisotopes for metastatic bone pain.
Roqué I Figuls M; Martinez-Zapata MJ; Scott-Brown M; Alonso-Coello P
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003347. PubMed ID: 28334435
[TBL] [Abstract][Full Text] [Related]
40. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
Nair N
J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
